EUVIMEDEUVIMED entdecken
Crossref

Super-Enhancer–Driven LncRNA UNC5B-AS1 Inhibits Inflammatory Phenotypic Transition in Pulmonary Artery Smooth Muscle Cells via Lactylation

Xiangrui Zhu iD, Xiangming Pang, Xiaoying Wang, Xiaoyu Guan, Yujing Tang, Zhaosi Wang, Lixin Zhang iD, Xiaodong Zheng iD, Fei Li, Jian Mei iD, Langlin Ou iD, Yuxiang Liu und 3 weitere

Arteriosclerosis, Thrombosis, and Vascular Biology · 2025-07 · 45 (7)

DOI: 10.1161/atvbaha.124.322174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025-07. Verfasst von Xiangrui Zhu und 14 weiteren Autor:innen. Beteiligte Einrichtung: College of Medical Laboratory Science and Technology (X. Zhu, X.P., Y.T., Z.W., L.Z., X. Zheng, J.M., L.O., Y.L., Z.M., Y.C., C.M.), Harbin Medical U…. Hauptthemen laut MEDLINE: Pulmonary Artery, RNA, Long Noncoding, Myocytes, Smooth Muscle, Muscle, Smooth, Vascular. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The phenotypic transition of pulmonary artery smooth muscle cells (PASMCs) is a central pathological alteration in pulmonary artery remodeling, contributing to pulmonary hypertension. Super-enhancers (SEs), characterized by histone modifications and the binding of coactivators, drive the expression of prominent genes that define cellular identity. However, the specific role of SEs, particularly SE-driven lncRNAs (long noncoding RNAs), in hypoxia-induced phenotypic plasticity of PASMCs remains unclear. METHODS: In this study, the lncRNA UNC5B antisense RNA 1 (UNC5B-AS1) regulated by SEs was screened in hypoxic PASMCs using RNA sequencing and H3K27ac (histone 3 lysine 27 acetylation) ChIP (chromatin immunoprecipitation) sequencing. Overexpression or knockdown of UNC5B-AS1 in vitro was performed to elucidate its role in pulmonary hypertension pathogenesis. A serotype 5 adenovirus-associated virus carrying a conserved functional fragment of UNC5B-AS1 was used to treat pulmonary hypertension in vivo. RESULTS: We identified UNC5B-AS1 as an SE-driven lncRNA transcriptionally activated by the transcription factor FOXP3 (forkhead box protein P3), which regulates phenotypic transition in PASMCs. Notably, we demonstrated that UNC5B-AS1 interacts with key glycolytic enzymes in the cytoplasm and likely serves as a molecular scaffold for LRPPRC (leucine-rich PPR motif-containing protein) and oxidative respiratory chain complex IV in mitochondria. Consequently, the deficiency of UNC5B-AS1 in PASMCs promotes the lactylation of promoter regions within inflammatory genes, including those of IL (interleukin)-1β, IL-6, and TNF-α (tumor necrosis factor-α), under hypoxic conditions, ultimately leading to inflammatory phenotypic transition of PASMCs. CONCLUSIONS: Our findings identify SE-driven UNC5B-AS1 as a novel regulatory factor in the hypoxia-induced phenotypic transition of PASMCs and suggest that overexpression of UNC5B-AS1 may represent a promising therapeutic strategy for pulmonary hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary ArteryRNA, Long NoncodingMyocytes, Smooth MuscleMuscle, Smooth, VascularVascular RemodelingInflammationAnimalsPhenotypeCells, CulturedForkhead Transcription FactorsDisease Models, AnimalMaleHumansMiceMice, Inbred C57BL

Stichwörter der Autor:innen

lactylationlong non-coding RNAphenotype transitionpulmonary artery smooth muscle cellpulmonary hypertensionsuper-enhancer

Substanzen

RNA, Long NoncodingForkhead Transcription Factors

Autor:innen und Institutionen

  • College of Medical Laboratory Science and Technology (X. Zhu, X.P., Y.T., Z.W., L.Z., X. Zheng, J.M., L.O., Y.L., Z.M., Y.C., C.M.), Harbin Medical University (Daqing), PR China.
  • College of Pharmacy (X.W.), Harbin Medical University (Daqing), PR China.
  • College of Pharmacy, Harbin Medical University, PR China (X.G.).
  • College of Basic Medicine (F.L.), Harbin Medical University (Daqing), PR China.
  • Institute of Cardiovascular Diseases, Xiamen Cardiovascular Hospital, School of Medicine, Xiamen University, Fujian Branch of National Clinical Research Center for Cardiovascular Diseases, PR China (C.M.).

ORCID-Profile: Xiangrui Zhu, Lixin Zhang, Xiaodong Zheng, Jian Mei, Langlin Ou, Yingli Chen, Cui Ma

Zitieren

APA

Zhu, X., Pang, X., Wang, X., Guan, X., Tang, Y., Wang, Z., Zhang, L., Zheng, X., Li, F., Mei, J., Ou, L., Liu, Y., Meng, Z., Chen, Y., & Ma, C. (2025). Super-Enhancer–Driven LncRNA UNC5B-AS1 Inhibits Inflammatory Phenotypic Transition in Pulmonary Artery Smooth Muscle Cells via Lactylation. Arteriosclerosis, Thrombosis, and Vascular Biology, 45(7). https://doi.org/10.1161/atvbaha.124.322174

Vancouver

Zhu X, Pang X, Wang X, Guan X, Tang Y, Wang Z, et al. Super-Enhancer–Driven LncRNA UNC5B-AS1 Inhibits Inflammatory Phenotypic Transition in Pulmonary Artery Smooth Muscle Cells via Lactylation. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025;45(7). doi:10.1161/atvbaha.124.322174

BibTeX
@article{Zhu2025,
  author = {Zhu, Xiangrui and Pang, Xiangming and Wang, Xiaoying and Guan, Xiaoyu and Tang, Yujing and Wang, Zhaosi and Zhang, Lixin and Zheng, Xiaodong and Li, Fei and Mei, Jian and Ou, Langlin and Liu, Yuxiang and Meng, Zitong and Chen, Yingli and Ma, Cui},
  title = {Super-Enhancer–Driven LncRNA UNC5B-AS1 Inhibits Inflammatory Phenotypic Transition in Pulmonary Artery Smooth Muscle Cells via Lactylation},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2025},
  volume = {45},
  number = {7},
  doi = {10.1161/atvbaha.124.322174}
}
Kostenlos starten →